Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Nilsson

Showing results (281-290 of 343) with videos related to

Pageof 35
Sort By:
Circulation|May 29, 2019
Lack of Ability to Present Antigens on Major Histocompatibility Complex Class II Molecules Aggravates Atherosclerosis in ApoE<sup>-/-</sup> MiceMaria Wigren, Sara Rattik, Ingrid Yao Mattisson, et al.
Rheumatology (Oxford, England)|March 9, 2024
Anti-histone and anti-nucleosome rather than anti-dsDNA antibodies associate with IFN-induced biomarkers in Sudanese and Swedish SLE patientsSahwa Elbagir, NasrEldeen A Mohammed, Vilija Oke, et al.
Cardiovascular Research|June 23, 2026
Associations of the inflammasome-dependent cytokine IL-18 with risk of coronary heart diseaseHarry Björkbacka, Isabel Gonçalves, Gunnar Engström, et al.
European Heart Journal|March 22, 2018
Altered metabolism distinguishes high-risk from stable carotid atherosclerotic plaquesLukas Tomas, Andreas Edsfeldt, Inês G Mollet, et al.
Circulation Research|May 22, 2020
S100A9 Links Inflammation and Repair in Myocardial InfarctionGoran Marinković, Duco Steven Koenis, Lisa de Camp, et al.
Stroke|July 6, 2019
sTRAIL-R2 (Soluble TNF [Tumor Necrosis Factor]-Related Apoptosis-Inducing Ligand Receptor 2) a Marker of Plaque Cell Apoptosis and Cardiovascular EventsIsabel Gonçalves, Pratibha Singh, Christoffer Tengryd, et al.
Vascular Pharmacology|April 15, 2021
Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosusIngrid Yao Mattisson, Sara Rattik, Harry Björkbacka, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 1, 2014
High plasma levels of heparin-binding epidermal growth factor are associated with a more stable plaque phenotype and reduced incidence of coronary eventsSara Rattik, Maria Wigren, Harry Björkbacka, et al.
Ebiomedicine|December 7, 2017
Elevated Markers of Death Receptor-Activated Apoptosis are Associated with Increased Risk for Development of Diabetes and Cardiovascular DiseaseIngrid Yao Mattisson, Harry Björkbacka, Maria Wigren, et al.
Diabetes, Obesity & Metabolism|September 5, 2018
Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: A nested, case-control studyAndrea Natali, Lorenzo Nesti, Elena Venturi, et al.
Pageof 35

Showing results (281-290 of 343) with videos related to

Sort By:
Pageof 35
Circulation|May 29, 2019
Lack of Ability to Present Antigens on Major Histocompatibility Complex Class II Molecules Aggravates Atherosclerosis in ApoE<sup>-/-</sup> MiceMaria Wigren, Sara Rattik, Ingrid Yao Mattisson, et al.
Rheumatology (Oxford, England)|March 9, 2024
Anti-histone and anti-nucleosome rather than anti-dsDNA antibodies associate with IFN-induced biomarkers in Sudanese and Swedish SLE patientsSahwa Elbagir, NasrEldeen A Mohammed, Vilija Oke, et al.
Cardiovascular Research|June 23, 2026
Associations of the inflammasome-dependent cytokine IL-18 with risk of coronary heart diseaseHarry Björkbacka, Isabel Gonçalves, Gunnar Engström, et al.
European Heart Journal|March 22, 2018
Altered metabolism distinguishes high-risk from stable carotid atherosclerotic plaquesLukas Tomas, Andreas Edsfeldt, Inês G Mollet, et al.
Circulation Research|May 22, 2020
S100A9 Links Inflammation and Repair in Myocardial InfarctionGoran Marinković, Duco Steven Koenis, Lisa de Camp, et al.
Stroke|July 6, 2019
sTRAIL-R2 (Soluble TNF [Tumor Necrosis Factor]-Related Apoptosis-Inducing Ligand Receptor 2) a Marker of Plaque Cell Apoptosis and Cardiovascular EventsIsabel Gonçalves, Pratibha Singh, Christoffer Tengryd, et al.
Vascular Pharmacology|April 15, 2021
Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosusIngrid Yao Mattisson, Sara Rattik, Harry Björkbacka, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 1, 2014
High plasma levels of heparin-binding epidermal growth factor are associated with a more stable plaque phenotype and reduced incidence of coronary eventsSara Rattik, Maria Wigren, Harry Björkbacka, et al.
Ebiomedicine|December 7, 2017
Elevated Markers of Death Receptor-Activated Apoptosis are Associated with Increased Risk for Development of Diabetes and Cardiovascular DiseaseIngrid Yao Mattisson, Harry Björkbacka, Maria Wigren, et al.
Diabetes, Obesity & Metabolism|September 5, 2018
Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: A nested, case-control studyAndrea Natali, Lorenzo Nesti, Elena Venturi, et al.
Pageof 35